ASSEMBLY BIOSCIENCES, INC. 8-K

What Happened
Assembly Biosciences, Inc. (ASMB) announced on May 7, 2026 that it issued a press release reporting its financial results for the quarter ended March 31, 2026. The press release was furnished as Exhibit 99.1 to the Form 8-K filed the same day.

Key Details

• Filing date: May 7, 2026 (Form 8-K reporting Item 2.02 and including Item 9.01 exhibits)
• Period reported: Quarter ended March 31, 2026
• Exhibit: Press release attached as Exhibit 99.1 (plus standard Inline XBRL cover page)
• Signed by: John O. Gunderson, VP, General Counsel and Corporate Secretary

Why It Matters
The furnished press release contains the company’s latest quarterly results — including items investors commonly watch such as revenue, expenses, net loss/profit, and cash position — which can affect near-term stock performance and investor expectations. Retail investors should read the attached Exhibit 99.1 for the specific financial figures and any management commentary or forward-looking information included in the release.